Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Andrea Corona MapLight reports mixed results in Schizophrenia trial In their Phase 2 ZEPHR trial, MapLights novel oral drug for schizophrenia, the Ml/M4 muscarinic agonist ML-007C-MA, successfully hit its primary endpoint but only for the twice-daily version, not the once-daily dose
Sunny Within Best For | A comprehensive supplement with NAD+ and CoQ10 Dose | 1 15-milliliter packet daily Prices starting at | $109
The formula combines two well-studied brightening agents, alpha-arbutin and glutathione, in a lightweight base that absorbs quickly, making it ideal for daily use even when temperatures and humidity climb
One of them had autism
US$ 20.04
US$ 23.72
US$ 20.23
US$ 21.32
US$ 24.28
US$ 29.39
US$ 27.09
US$ 21.39
US$ 21.80
US$ 20.41
